Boston-based biotech company Ginkgo Bioworks will make its market debut by merging with Soaring Eagle Acquisition Corp., the blank-check company led by former MGM CEO Harry Sloan. Ginkgo was started in 2009 by a team of MIT scientists intent on building made-to-order microbes that enable customers to grow rather than manufacture better products. The company calls itself the “organism company” because it designs and prints DNA, the building blocks that support all living things. The deal, worth $17.5 billion, including a $15 billion valuation for Ginkgo and $2.5 billion in deal proceeds, would make it one of the largest SPAC mergers to date.
Read the full article: Bill Gates-Backed Ginkgo Bioworks Going Public via $15B SPAC //
Source: https://www.cnbc.com/2021/05/11/bill-gates-backed-ginkgo-bioworks-going-public-in-15-billion-spac-.html